pharmaphorum April 30, 2019
Germany precision medicine market exceeded USD 2.6 billion in 2017 and high segmental growth will be due to the growing pediatric as well as adult population susceptible to metabolic diseases such as diabetes. According to NCBI, prevalence of Type 2 diabetes is high in the German population. Researchers and scientists have geared up efforts to develop precision medicines that are altered according to patient’s genome ensuring efficient treatment of genetic disorders. Moreover, high income levels and developed healthcare infrastructure will prove beneficial for Germany precision medicine industry growth in future.
U.S. precision medicine market held the highest revenue of USD 18 billion in 2017 and will show similar trend in the coming years. Various government initiatives to increase the adoption...
Today's Sponsors
Today's Sponsor